Determination of amino acid pairs sensitive to variants in human Bruton's tyrosine kinase by means of a random approach

Molecular Simulation

Volumn 29, Issue 4, 2003, Pages 249-254

  Wu, Guang ^a   Yan, Shaomin ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Agammaglobulinemia; Bruton's tyrosine kinase; Probability; Randomness

Indexed keywords

DATA REDUCTION; ENZYME KINETICS; MUTAGENS; PROBABILITY; PROTEINS; RANDOM PROCESSES;

AGAMMAGLOBULINEMIA; BRUTON'S TYROSINE KINASE; RANDOMNESS;

AMINO ACIDS;

EID: 0842276870     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/0892702031000101321     Document Type: Article

References (21)

1. Chou, K.C. (1999) "Using pair-coupled amino acid composition to predict protein secondary structure content", Protein Eng. 12, 1041-1050.
2. Liu, W. and Chou, K.C. (1999) "Prediction of protein secondary structure content", J. Protein Chem. 18, 473-480.
3. Wu, G. and Yan, S.M. (2002a) "Randomness in the primary structure of protein: methods and implications", Mol. Biol. Today 3, 55-69.
4. Wu, G. and Yan, S.M. (2003) "Determination of amino acid pairs in human haemoglobin α chain sensitive to variants by means of a random approach", Comp. Clin. Path., In Press.
5. Wu, G. and Yan, S.M. (2002b) "Determination of amino acid pairs in human phenylalanine hydroxylase protein sensitive to variants by means of a random approach", Peptides 23, 2085-2090.
6. Rawlings, D.J. (1999) "Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function", Clin. Immunol. 91, 243-253.
7. LeBien, T.W. (2000) "Fates of human B-cell precursors", Blood 96, 9-23.
8. Bruton, O. (1952) "Agammaglobulinemia", Pediatrics 9, 722-728.
9. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R., Bobrow, M., Smith, C.I.E. and Bentley, D.R. (1993) "The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein tyrosine kinase", Nature 361, 226-233.
10. Tsukada, S., Saffran, D.C., Rawlings, D.J., Parolini, O., Allen, R.C., Klisak, I., Sparkes, R.S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J. W., Cooper, M.D., Conley, M.E. and Witte, O.N. (1993) "Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia", Cell 72, 279-290.
11. Rosen, F.S., Wedgwood, R.J., Eibl, M.M., et al. (1997) "Primary immunodeficiency diseases: report of a WHO scientific group", Clin. Exp. Immunol. 109(Suppl.), S1.
12. Fischer, A. and Malissen, B. (1998) "Natural and engineered disorders of lymphocyte development", Science 280, 237-243.
13. Conley, M.E. and Cooper, M.D. (1998) "Genetic basis of abnormal B cell development", Curr. Opin. Immunol. 10, 399-406.
14. Bairoch, A. and Apweiler, R. (2000) "The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 2000", Nucleic Acids Res. 28, 45-48.
15. Feller, W. (1968) An Introduction to Probability Theory and Its Applications, 3rd Ed. (Wiley, New York) Vol. I.
16. Rideout, W.M., Coetzee, G.A., Olumi, A.F. and Jones, P.A. (1990) "5-Methylcytosine as an endogenous mutagen in human LL receptor and p53 genes", Science 249, 1288-1290.
17. Montesano, R., Hainaut, P. and Wild, C.P. (1997) "Hepatocellular carcinoma: from gene to public health", J. Natl Cancer Inst. 89, 1844-1851.
18. Hainaut, P. and Pfeifer, G.P. (2001) "Patterns of p53 G → T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke", Carcinogenesis 22, 367-374.
19. Ory, K., Legros, Y., Auguin, C. and Soussi, T. (1994) "Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation", EMBO J. 13, 3496-3504.
20. Forrester, K., Lupold, S.E., Ott, V.L., Chay, C.H., Band, V., Wang, X.W. and Harris, C.C. (1995) "Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent", Oncogene 10, 2103-2111.
21. Aas, T., Borresen, A.L., Geisler, S., Smith-Sorensen, B., Johnsen, H., Varhaug, J.E., Akslen, L.A. and Lonning, P.E. (1996) "Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients", Nat. Med. 2, 811-814.